Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage

2024-12-25T10:05:11+0800

Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins 'Fast Money' to talk Zepbound's recent trial results and what it means for Eli Lilly's future growth.